Effectiveness of Adjuvant Fluorouracil in Clinical Practice: A Population-Based Cohort Study of Elderly Patients With Stage III Colon Cancer

This publication has 58 references indexed in Scilit:

• A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
  New England Journal of Medicine, 2001
• Colorectal cancer
  The Lancet, 1999
• Determinants of patient participation in clinical studies requiring informed consent: Why patients enter a clinical trial
  Patient Education and Counseling, 1998
• Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
  Journal of Clinical Oncology, 1997
• Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report
  Annals of Internal Medicine, 1995
• The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.
  Journal of Clinical Oncology, 1993
• Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation
  Social Science & Medicine, 1991
• Adjuvant Therapy for Patients With Colon and Rectal Cancer
  JAMA, 1990
• Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
  New England Journal of Medicine, 1990
• Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.
  Journal of Clinical Oncology, 1989